3 news items
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
VRNA
9 May 24
credits or reliefs or exposure to additional tax liabilities or assessments could affect our profitability, and audits by tax authorities could
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
HTGC
VRNA
9 May 24
, unavailability of certain tax credits or reliefs or exposure to additional tax liabilities or assessments could affect our profitability, and audits by tax
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
VRNA
2 May 24
or exposure to additional tax liabilities or assessments could affect our profitability, and audits by tax authorities could result in additional tax
- Prev
- 1
- Next